Online Exercise Program for Gynecologic Cancer Survivors
This study is testing an individualized online exercise program for women who have completed treatment for gynecologic cancer (like uterine, ovarian, or cervical cancer). The program aims to help improve symptoms such as pain, fatigue, sleep problems, depression, and memory issues, which can affect quality of life. Researchers will also look at how the exercise program impacts the gut microbiome (the bacteria and other tiny organisms in your digestive system). You would participate in an online home-based exercise program using Zoom. The study is looking for 40 participants and is currently unclear on its recruitment status.
- Study design
- This is an interventional study with a planned enrollment of 40 participants. It is not specified if it is randomized or blinded.
- What's involved
- You would meet with an exercise trainer, complete a functional assessment, and participate in an individualized online exercise program twice a week for 12 weeks. You would also wear an activity tracker and complete questionnaires.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary endpoints for this study are measured at 12 weeks.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
An Individualized Online Home-Based Exercise Program for Improving Symptoms in Gynecologic Cancer Survivors
At a glance
Conditions
Where it's being run
4 sites across 1 statesStudy leadership
- Zahra A Barandouzi, Ph.D.,MSN,RN · PRINCIPAL_INVESTIGATOR · Emory University Hospital/Winship Cancer Institute
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Attrition Rates (Feasibility)At 12 weeks
Feasibility will be assessed by calculating attrition and adherence rates, identifying reasons for refusal, and evaluating the completeness of the data. We will consider the intervention to have low attrition and high adherence if \>80% of participants remain enrolled and complete the study, respectively.
- Adherence Rates (Feasibility)At 12 weeks
Feasibility will be assessed by calculating attrition and adherence rates, identifying reasons for refusal, and evaluating the completeness of the data. We will consider the intervention to have low attrition and high adherence if \> 80% of participants remain enrolled and complete the study, respectively.
- Intervention AcceptabilityUp to 12 weeks
Will be evaluated with a survey to assess participants' perceptions of the acceptability of the study procedures. A response rate of \> 80% will be considered high acceptability. Descriptive statistics will be calculated using SPSS and R software.
- Gut MicrobiomeFrom baseline to 12 weeks
Gut microbiota composition will be evaluated using collected stool samples. The preliminary efficacy of the intervention on gut microbiome and psychoneurological symptoms (PNS) will be compared using a paired t-test.
- Psychoneurological SymptomsFrom baseline to 12 weeks
Will be assessed using the Fatigue Short Form, Patient-Reported Outcomes Measurement Information System (PROMIS) Emotional Distress-Depression and Anxiety Short Form, Pain Interference Short Form, PROMIS Cognitive Function Short Form, PROMIS Sleep Disturbance Short Form, the PROMIS gastrointestinal (GI) constipation and diarrhea Short Forms. The preliminary efficacy of the intervention on gut microbiome and PNS will be compared using a paired t-test.